{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T10:50:21Z","timestamp":1782989421737,"version":"3.54.5"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The preferred method of antibiotic administration for peritoneal dialysis-related peritonitis is intraperitoneal. However, there are few studies on the compatibility of antibiotics in amino acid-based peritoneal dialysate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Our study employed High Performance Liquid Chromatography (HPLC) and amino acid analyzer to evaluate the stability of different antibiotics in amino acid-based peritoneal dialysate. We also used the two-dose method to detect the antimicrobial potency of gentamicin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Gentamicin, ciprofloxacin, heparin Sodium and fluconazole showed excellent stability under different conditions (14 days at 4\u00a0\u00b0C: \u22643.57%, 14 days at 25\u00a0\u00b0C: \u22643.77%). \u03b2-Lactam antibiotics including meropenem, ceftazidime, cefotaxime, and aztreonam showed significant degradation, especially at high temperature (37\u00a0\u00b0C)(14 days at 4\u00a0\u00b0C: \u226459.98%, 14 days at 25\u00a0\u00b0C: 19.06%\u201384.97%, except for aztreonam demonstrating degradation at 48\u00a0h at 37\u00a0\u00b0C (18.51%\u201341.88%). Among them, meropenem was the least stable (14 days at 4\u00a0\u00b0C: 59.98%, 14 days at 25\u00a0\u00b0C: 84.97%). Low concentration vancomycin is relatively stable, while medium and high concentration vancomycin has poor stability (14 days at 4\u00a0\u00b0C 500\u00a0mg\/L: 45.8%, 1\u00a0g\/L 27.7%). Most amino acids remained basically stable under different antibiotic environments. We counted the degradation rate of all amino acids under different conditions. The maximum degradation rate appeared on glycine, but it was only 8.21%. Finally, we also found that the antibacterial efficacy of gentamicin in acid-based peritoneal dialysate was enhanced.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Most antibiotics are stable in amino acid-based peritoneal dialysate. However, \u03b2-lactams (especially meropenem, ceftazidime, and cefotaxime) and medium-to-high dose vancomycin showed significant degradation and require prompt administration. The nutritional amino acid profile in dialysate remains largely unaffected. Gentamicin demonstrates enhanced antibacterial activity in the amino acid-based peritoneal dialysate.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1808066","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T10:00:45Z","timestamp":1782986445000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Intraperitoneal administertion: compatibility and stability of common antibiotics in amino acid-based peritoneal dialysate"],"prefix":"10.3389","volume":"17","author":[{"given":"Bohua","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Nephrology, West China Hospital of Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichao","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Nephrology, West China Hospital of Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueli","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Nephrology, West China Hospital of Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Nephrology, West China Hospital of Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Nephrology, West China Hospital of Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliu","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, West China Hospital of Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoxi","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, West China Hospital of Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1177\/089686089501500408","article-title":"Stability of drug additives to peritoneal dialysate","volume":"15","author":"Bailie","year":"1995","journal-title":"Perit. Dial. Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1177\/11297298211015083","article-title":"Management of peritoneal dialysis Mycobacterium abscessus exit-site infection: a case report and literature review","volume":"23","author":"Bartolomeo","year":"2022","journal-title":"J. Vasc. Access"},{"key":"B3","doi-asserted-by":"publisher","first-page":"723","DOI":"10.2215\/CJN.05720809","article-title":"Biocompatible peritoneal dialysis solutions: do we have one?","volume":"5","author":"Chaudhary","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1177\/08968608231196034","article-title":"Stability and compatibility of intraperitoneal antimicrobials in peritoneal dialysate solutions","volume":"43","author":"Churchwell","year":"2023","journal-title":"Perit. Dial. Int."},{"key":"B5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3747\/pdi.2016.00023","article-title":"Intraperitoneal meropenem for polymicrobial peritoneal dialysis-related peritonitis","volume":"36","author":"de Fijter","year":"2016","journal-title":"Perit. Dial. Int."},{"key":"B6","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3747\/pdi.2015.00018","article-title":"Stability and compatibility of antibiotics in peritoneal dialysis solutions applied to automated peritoneal dialysis in the pediatric population","volume":"36","author":"Deslandes","year":"2016","journal-title":"Perit. Dial. Int."},{"key":"B7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/jac\/32.2.325","article-title":"Nephrotoxicity of vancomycin and aminoglycoside therapy separately and in combination","volume":"32","author":"Goetz","year":"1993","journal-title":"J. Antimicrob. Chemother."},{"key":"B8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/jac\/46.1.79","article-title":"Pharmacodynamics of vancomycin and ampicillin alone and in combination with gentamicin once daily or thrice daily against Enterococcus faecalis in an in vitro infection model","volume":"46","author":"Houlihan","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"B9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.7180\/kmj.2013.28.1.43","article-title":"Extended spectrum \u03b2-lactamase\u2013producing E. Coli-related nosocomial peritonitis treated successfully with meropenem in a patient on peritoneal dialysis","volume":"28","author":"Jeong","year":"2013","journal-title":"Kosin Med. J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e02086","DOI":"10.1128\/mbio.02086-20","article-title":"Na+-NQR confers aminoglycoside resistance via the regulation of l-Alanine metabolism","volume":"11","author":"Jiang","year":"2020","journal-title":"mBio"},{"key":"B11","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3747\/pdi.2015.00161","article-title":"Influence of different peritoneal dialysis fluids on the in vitro activity of cefepime, ciprofloxacin, ertapenem, meropenem and tobramycin against Escherichia coli","volume":"36","author":"Kussmann","year":"2016","journal-title":"Perit. Dial. Int."},{"key":"B12","doi-asserted-by":"publisher","first-page":"6512","DOI":"10.1038\/s41598-019-42854-y","article-title":"Compatibility of ciprofloxacin with commercial peritoneal dialysis solutions","volume":"9","author":"Kussmann","year":"2019","journal-title":"Sci. Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0272-6386(03)00421-9","article-title":"A 3-year, prospective, randomized, controlled study on amino acid dialysate in patients on CAPD","volume":"42","author":"Li","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3747\/pdi.2016.00078","article-title":"ISPD peritonitis recommendations: 2016 update on prevention and treatment","volume":"36","author":"Li","year":"2016","journal-title":"Perit. Dial. Int."},{"key":"B15","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3747\/pdi.2015.00062","article-title":"Stability of antibiotics for intraperitoneal administration in extraneal 7.5% icodextrin peritoneal dialysis bags (STAB study)","volume":"36","author":"Ranganathan","year":"2016","journal-title":"Perit. Dial. Int."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1093\/jac\/dks510","article-title":"Stability and compatibility of vancomycin for administration by continuous infusion","volume":"68","author":"Raverdy","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1093\/ckj\/sfac012","article-title":"Stability and compatibility of antibiotics in peritoneal dialysis solutions","volume":"15","author":"So","year":"2022","journal-title":"Clin. Kidney J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1038\/s41598-020-58391-y","article-title":"Compatibility of aztreonam in four commercial peritoneal dialysis fluids","volume":"10","author":"Tobudic","year":"2020","journal-title":"Sci. Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fmicb.2021.759170","article-title":"Exogenous citrulline and glutamine contribute to reverse the resistance of salmonella to apramycin","volume":"12","author":"Yong","year":"2021","journal-title":"Front. Microbiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.3389\/fmicb.2020.01919","article-title":"Synergistic potential of antimicrobial combinations against methicillin-resistant Staphylococcus aureus","volume":"11","author":"Yu","year":"2020","journal-title":"Front. Microbiol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1808066\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T10:00:47Z","timestamp":1782986447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1808066\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":20,"alternative-id":["10.3389\/fphar.2026.1808066"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1808066","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"article-number":"1808066"}}